The DOI matches its Crossref record; 445 of the 445 references it cites were found in a registry or an index.
Tissue invasion and metastasis: Molecular, biological and clinical perspectives
Open accessAbstract
Cancer is a key health issue across the world, causing substantial patient morbidity and mortality. Patient prognosis is tightly linked with metastatic dissemination of the disease to distant sites, with metastatic diseases accounting for a vast percentage of cancer patient mortality. While advances in this area have been made, the process of cancer metastasis and the factors governing cancer spread and establishment at secondary locations is still poorly understood. The current article summarizes recent progress in this area of research, both in the understanding of the underlying biological processes and in the therapeutic strategies for the management of metastasis. This review lists the disruption of E-cadherin and tight junctions, key signaling pathways, including urokinase type plasminogen activator (uPA), phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene (PI3K/AKT), focal adhesion kinase (FAK), β-catenin/zinc finger E-box binding homeobox 1 (ZEB-1) and transforming growth factor beta (TGF-β), together with inactivation of activator protein-1 (AP-1) and suppression of matrix metalloproteinase-9 (MMP-9) activity as key targets and the use of phytochemicals, or natural products, such as those from Agaricus blazei, Albatrellus confluens, Cordyceps militaris, Ganoderma lucidum, Poria cocos and Silybum marianum, together with diet derived fatty acids gamma linolenic acid (GLA) and eicosapentanoic acid (EPA) and inhibitory compounds as useful approaches to target tissue invasion and metastasis as well as other hallmark areas of cancer. Together, these strategies could represent new, inexpensive, low toxicity strategies to aid in the management of cancer metastasis as well as having holistic effects against other cancer hallmarks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 401–445 of 445
Role of inflammation in oral carcinogenesis (Part II): CD8, FOXP3, TNF-α, TGF-β and NF-κB expression
Piva, M. R., de Souza, L. B., Martins‐Filho, P. R., Nonaka, C. F. W., Santos, T. D. S., Andrade, E. S. D. S., & PIVA, D. (2013) · Oncology Letters · doi:10.3892/ol.2013.1302 · Cited by 37
Jat, P., Perkins, N. D., & Mowla, S. N. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s36160 · Cited by 37
Harada (2010) · International Journal of Oncology · doi:10.3892/ijo_00000711 · Cited by 37
Sasaki, T., Kuniyasu, H., Luo, Y., Kitayoshi, M., Tanabe, E., Kato, D., Shinya, S., Fujii, K., Ohmori, H., & Yamashita, Y. (2013) · Pathobiology · doi:10.1159/000351721 · Cited by 37
Lu, J., Sun, L., Lin, Z., Duan, X., Ge, Z., Xing, E., Lan, T., Yang, N., Li, X., Li, M., et al. (2013) · Phytotherapy Research · doi:10.1002/ptr.4980 · Cited by 36
Mineharu, Y., Muhammad, A. G., Yagiz, K., Candolfi, M., Kroeger, K. M., Xiong, W., Puntel, M., Liu, C., Levy, E., Lugo, C., et al. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0144-7 · Cited by 36
Differential Regulation of Growth-Promoting Signalling Pathways by E-Cadherin
Georgopoulos, N. T., Kirkwood, L. A., Walker, D., & Southgate, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013621 · Cited by 36
Antimetastatic and Immunomodulating Effect of Water Extracts From Various Mushrooms
Han, S.-S., Cho, C.-K., Lee, Y.-W., & Yoo, H. (2009) · Journal of Acupuncture and Meridian Studies · doi:10.1016/s2005-2901(09)60058-3 · Cited by 36
Botta, C., Bestoso, E., Apollinari, S., Cusi, M. G., Pastina, P., Abbruzzese, A., Sperlongano, P., Misso, G., Caraglia, M., Tassone, P., et al. (2012) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31825943aa · Cited by 35
Chen, J., Jin, X., Chen, J., & Liu, C. (2013) · Tumor Biology · doi:10.1007/s13277-013-0746-7 · Cited by 35
Tedelind, S., Ericson, L. E., KARLSSON, J., & Nilsson, M. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490215 · Cited by 34
Mullin, J. M. (1997) · Carcinogenesis · doi:10.1093/carcin/18.12.2339 · Cited by 33
Balkovetz, D. F., Gerrard, E. R., Li, S., Johnson, D., Lee, J., Tobias, J. W., Rogers, K. K., Snyder, R. W., & Lipschutz, J. H. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00270.2003 · Cited by 33
Portanova, P., Notaro, A., Pellerito, O., Sabella, S., Giuliano, M., & Calvaruso, G. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1945 · Cited by 32
Kirkwood, J. M., Gonzalez, R. C., Reintgen, D. S., Clingan, P. R., McWilliams, R. R., de Alwis, D. P., Zimmermann, A. H., Brown, M. P., Ilaria, R. L., & Millward, M. J. (2011) · Cancer · doi:10.1002/cncr.26068 · Cited by 31
Silva, A. F., Sartori, D., Macedo, F., Ribeiro, L. R., Fungaro, M. H. P., & Mantovani, M. S. (2013) · Human & Experimental Toxicology · doi:10.1177/0960327112468173 · Cited by 31
Ilkovitch, D., & Lopez, D. M. (2009) · Blood · doi:10.1182/blood-2008-08-176438 · Cited by 29
Doki, Y., Ishikawa, O., Mano, M., Hiratsuka, M., Sasaki, Y., Kameyama, M., Ohigashi, H., Murata, K., Yamada, T., Miyashiro, I., et al. (2002) · Journal of Surgical Research · doi:10.1006/jsre.2002.6506 · Cited by 29
Kubota, H., Matsumoto, H., Higashida, M., Murakami, H., Nakashima, H., Oka, Y., Okumura, H., Yamamura, M., Nakamura, M., & Hirai, T. (2013) · PubMed · Cited by 28
Phenylbutyric acid induces the cellular senescence through an Akt/p21WAF1 signaling pathway
Kim, H. D., Jang, C., Choe, J. M., Sohn, J., & Kim, J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.04.086 · Cited by 28
Kang, M.-I., Baker, A., Dextras, C., Cabarcas‐Petroski, S., Young, M. R., & Colburn, N. H. (2012) · Genes & Cancer · doi:10.1177/1947601912448820 · Cited by 28
Luo, X.-J., Li, W., Yang, L.-F., Yu, X.-F., Xiao, L.-B., Tang, M., Dong, X., Deng, Q., Bode, A. M., Liu, J.-K., et al. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.08.026 · Cited by 28
Zingg, U., Montani, M., Busch, M., Metzger, U. F., Went, P., & Oertli, D. (2009) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2008.12.001 · Cited by 27
Zhang, H., Chen, J., Zeng, Z., & Que, W. (2013) · Journal of International Medical Research · doi:10.1177/0300060513480920 · Cited by 27
Ono, Y., Hayashida, T., Konagai, A., Okazaki, H., Miyao, K., Kawachi, S., Tanabe, M., Shinoda, M., Jinno, H., Hasegawa, H., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02133.x · Cited by 25
Eynard, A. R., Jiang, W. G., & Mansel, R. E. (1998) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(98)90098-9 · Cited by 24
Self-citationDirect Cytotoxicity of Lentinula edodes Mycelia Extract on Human Hepatocellular Carcinoma Cell Line
Yukawa, H., Ishikawa, S., Kawanishi, T., Tamesada, M., & Tomi, H. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b110657 · Cited by 23
Ponnala, S., Chetty, C., Veeravalli, K. K., Dinh, D. H., Klopfenstein, J. D., & Rao, J. S. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.08.001 · Cited by 23
Sclareol reduces CD4+ CD25+ FoxP3+ Treg cells in a breast cancer model in vivo.
Noori, S., Hassan, Z. M., & Salehian, O. (2013) · PubMed · doi:10.22034/iji.2013.16799 · Cited by 23
Han, L., Peng, B., Ma, Q., Ma, J., Li, J., Li, W., Duan, W., Chen, C., Liu, J., Xu, Q., et al. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990249 · Cited by 22
Maritz, M. F., van der Watt, P. J., Holderness, N., Birrer, M. J., & Leaner, V. D. (2011) · Biological Chemistry · doi:10.1515/bc.2011.036 · Cited by 20
Anti-invasive and antiangiogenic effects of MMI-166 on malignant glioma cells
Nakabayashi, H., Yawata, T., & Shimizu, K. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-339 · Cited by 20
Simon, G. R., Ilaria, R. L., Sovak, M. A., Williams, C. C., Haura, E. B., Cleverly, A. L., Sykes, A. K., Wagner, M. M., de Alwis, D. P., Slapak, C. A., et al. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1593-0 · Cited by 19
Scheunemann, P., Stoecklein, N. H., Hermann, K., Rehders, A., Eisenberger, C. F., Knoefel, W. T., & Hosch, S. B. (2008) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-008-0369-4 · Cited by 19
Bøtkjær, K. A., Deryugina, E. I., Dupont, D. M., Gårdsvoll, H., Bekes, E. M., Thuesen, C. K., Chen, Z., Ploug, M., Quigley, J. P., & Andreasen, P. A. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0349 · Cited by 18
Yousefi, M., Ghaffari, S. H., Soltani, B. M., Nafissi, S., Momeny, M., Zekri, A., Behmanesh, M., Alimoghaddam, K., & Ghavamzadeh, A. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0827-9 · Cited by 17
Jiang, W. G., Ye, L., Ji, K., Ruge, F., Wu, Y., Gao, Y., Ji, J., & MASON, M. D. (2013) · Oncology Reports · doi:10.3892/or.2013.2586 · Cited by 17
Self-citationHarnack, U., Johnen, H., & Pecher, G. (2010) · PubMed · Cited by 17
Katakura, Y., Nakata, E., Tabira, Y., Miura, T., Teruya, K., Tsuchiya, T., & Shirahata, S. (2003) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.67.815 · Cited by 16
Partners in death: a role for p73 and NF-kB in promoting apoptosis
Vousden, K. H. (2009) · Aging · doi:10.18632/aging.100033 · Cited by 15
Eitsuka, T., Nakagawa, K., & Miyazawa, T. (2004) · BioFactors · doi:10.1002/biof.552210105 · Cited by 13
Liu, Y., Xu, Y., 孙嘉斌, Ma, A., Zhang, F., Xia, S., Xu, G., & Liu, Y. (2013) · European Journal of Immunology · doi:10.1002/eji.201243291 · Cited by 11
Andjilani, M., Droz, J., Benahmed, M., & Tabone, É. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.2.535 · Cited by 11
Re: Role of Transforming Growth Factor- Signaling in Cancer
Li, C., Garland, J. M., & Kumar, S. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.7.555 · Cited by 8
Effect of FAK, DLC-1 gene expression on OVCAR-3 proliferation
Liu, H., Shi, H., Hao, Y., et al. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1956-6 · Cited by 6
Cited by
Abed, J., Emgård, J. E. M., Zamir, G., Faroja, M., Almogy, G., Grenov, A., Sol, A., Naor, R., Pikarsky, E., Atlan, K. A., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.07.006 · Cited by 888
Bisphenol A (BPA) and cell signaling pathways
Murata, M., & Kang, J.-H. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.12.002 · Cited by 361
Recent advances in magnetic fluid hyperthermia for cancer therapy
Das, P., Colombo, M., & Prosperi, D. (2019) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2018.10.051 · Cited by 329
Rynkeviciene, R., Simiene, J., Strainiene, E., Stankevicius, V., Usinskiene, J., Miseikyte Kaubriene, E., Meskinyte, I., Cicenas, J., & Suziedelis, K. (2018) · Cancers · doi:10.3390/cancers11010017 · Cited by 136
Stroma in normal and cancer wound healing
Huet, E., Jaroz, C., Nguyen, H. Q., Belkacemi, Y., de la Taille, A., Stavrinides, V., & Whitaker, H. (2019) · The FEBS Journal · doi:10.1111/febs.14842 · Cited by 42
Metadata
- Authors
- Jiang, W. G., Sanders, A. J., Katoh, M., Ungefroren, H., Gieseler, F., Prince, M., Thompson, S. K., Zollo, M., Spano, D., Dhawan, P., Sliva, D., Subbarayan, P. R., Sarkar, M., Honoki, K., Fujii, H., Georgakilas, A. G., Amedei, A., Niccolai, E., Amin, A., Ashraf, S. S., Ye, L., Helferich, W. G., Yang, X., Boosani, C. S., Guha, G., Ciriolo, M. R., Aquilano, K., Chen, S., Azmi, A. S., Keith, W. N., Bilsland, A., Bhakta, D., Halicka, D., Nowsheen, S., Pantano, F., & Santini, D.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 35
- Pages
- S244-S275
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2008514427
- Cited by
- 515
- References
- 445
- FWCI
- 18.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.